From: Clinical utility of cardiac magnetic resonance T2 mapping for acute myocardial edema
Total cases | 65 | Â | Â | Â | Â |
---|---|---|---|---|---|
Group | Controls | Transplant | AMI | Myocarditis | Cardiomyopathy |
Average age | 32.7 ± 7.3 | 55.8 ± 13.8 | 55.5 ± 10.3 | 49.2 ± 13.2 | 60 |
Percent female | 50% | 44% | 33% | 33% | 100% |
Normal** | 20 | 22 | 4 | 3 | 0 |
Disease | NA | 3 | 8 | 3 | 1 |
Total | 20 | 25 | 12 | 6 | 1 |
Outcomes | Â | Â | Â | Â | Â |
Average T2 Normal ROI (ms) | 51.2 ± 2.7 | 52.1 ± 2.4 | 54.1 ± 3.1 | 54.0 ± 3.7 | 52.3 ± 3.1 |
Average T2 Disease ROI (ms) | NA | 61.6 ± 3.1 | 65.0 ± 4.4 | 67.1 ± 7.5 | 68.0 ± 4.2 |
Significance | NA | <0.05 | <0.05 | <0.05 | <0.05* |
Ejection fraction | 62% | 58.7% | 39.$% | 41/1% | 32.2% |